Company intelligence / Profile preview

Perosphere Technologies

Danbury, Connecticut, United Statesperospheretech.com ↗

Ownership: Private
Development stage: Commercial

Overview

Perosphere Technologies has developed the ClotChek™, a novel point-of-care diagnostic device that rapidly measures whole blood clotting times and the pharmacodynamic effects of direct oral anticoagulants using a single drop of blood. The device delivers results within minutes and aims to improve decision-making for diagnosis, treatment, and prevention in coagulation management. The technology has CE Mark approval in Europe but has not yet received FDA clearance in the United States. Clinical validation studies have shown encouraging performance compared to standard methods.

Therapeutic areas: CardiovascularHematology
Modalities: DeviceDiagnostic assay (pharmacodynamic, reagent-free assay)Microfluidic chip-based universal coagulation assay
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Perosphere Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Perosphere Technologies.